MedTrace Logo

Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)

NCT03946085 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2019-05-10

No results posted yet for this study

Summary

The aim of this study is to evaluate the clinical benefits in visual function from dietary supplementation of the Lumega-Z carotenoid liquid-supplement in participants with drusen and at risk of AMD. The effects of Lumega-Z supplementation will be compared to an active comparator, the AREDS2 multivitamin.

Conditions

  • Retinal Drusen
  • Age-related Macular Degeneration
  • Macular Degeneration

Interventions

DIETARY_SUPPLEMENT

Lumega-Z

A specially-formulated carotenoid supplement formula that utilizes a micronized, lipid-based liquid form of delivery.

DIETARY_SUPPLEMENT

AREDS2

A commercially-available multivitamin soft gel formula.

Sponsors & Collaborators

  • Western University of Health Sciences

    collaborator OTHER

  • Eye Clinic of Austin

    collaborator OTHER

  • Guardion Health Sciences, Inc.

    lead INDUSTRY

Principal Investigators

  • T Henderson · Eye Clinic of Austin

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-19
Primary Completion
2018-10-23
Completion
2018-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03946085 on ClinicalTrials.gov